In tests on mice, twice higher survival was achieved by the activation of two independent pathways triggering apoptotic tumor cell death, one with p53 and the other with BMF, a pro-apoptotic protein that was activated after the PI3K-AKT-mTORC1 pathway was inhibited. The gene discussed is TP53; the disease is neoplasm.